Jobs / United States / Gilead Sciences INC
Director, QC Technology & Innovation
Gilead Sciences INC · 🇺🇸 United States - California - La Verne
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Gilead Sciences INC paid sponsored hires in similar roles5 certified filings for “Assoc Director, R&D Information Systems” (Computer and Information Systems Managers) in CA: $198k–$211k, median $209k. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Gilead Sciences INC
The US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Gilead Sciences INC →
About the role
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together. Job Description Director, QC Technology & Innovation, La Verne, CA Position Summary The Director, QC Technology & Innovation reports to the Site QC Head and provides scientific and technical leadership for QC technology, analytical methods, method transfer, and laboratory innovation. This role is responsible for driving the adoption and implementation of new instruments, testing technologies, digital solutions, and automation, while strengthening the scientific understanding and robustness of analytical methods. The Director will also lead analytical method transfers and complex technical troubleshooting to ensure QC capabilities evolve with the site’s portfolio and business needs. The role will advance QC toward a highly automated, digitally integrated, and low-touch laboratory environment, leveraging emerging analytical technologies, automation, robotics, and innovative testing approaches. Core Accountabilities 1. Technology & Innovation • Lead implementation of the site QC technology and innovation strategy in collaboration with Global Quality, ensuring alignment with the Global Quality Digital and Innovation Strategy, enterprise priorities, and future-state vision. • Collaborate with global and site stakeholders to identify, evaluate, and implement laboratory instruments, analytical technologies, automation, digital solutions, and testing approaches that align with global strategies and standards. • Develop and maintain a future-state QC technology roadmap aligned with the global vision and roadmaps, progressively enabling automated, integrated, and low-touch testing across the network. • Partner across site and global functions to identify opportunities to automate end-to-end analytical workflows, reduce manual interventions and handoffs, and improve data flow and testing efficiency in alignment with global process and digital strategies. • Lead proof-of-concept studies and technical assessments for emerging technologies in collaboration with global subject matter experts, sharing outcomes to support coordinated investment and scalable adoption. • Drive modernization and simplification of laboratory testing in alignment with the global quality vision, leveraging network standards, shared capabilities, and best practices to improve efficiency, reliability, and analytical capability. 2. Method Transfer & New Product Introduction • Lead analytical method transfers supporting new product introduction, PPQ, commercial manufacturing, and product lifecycle changes. • Assess method readiness, technical risks, instrumentation requirements, laboratory capability, and training needs.